nach oben

Seminars in Immunopathology

Erschienen in:

27.03.2017 | Review

Arthritis models: usefulness and interpretation

verfasst von: Natacha Bessis, Patrice Decker, Eric Assier, Luca Semerano, Marie-Christophe Boissier

Erschienen in: Seminars in Immunopathology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Animal models of arthritis are used to better understand pathophysiology of a disease or to seek potential therapeutic targets or strategies. Focusing on models currently used for studying rheumatoid arthritis, we show here in which extent models were invaluable to enlighten different mechanisms such as the role of innate immunity, T and B cells, vessels, or microbiota. Moreover, models were the starting point of in vivo application of cytokine-blocking strategies such as anti-TNF or anti-IL-6 treatments. The most popular models are the different types of collagen-induced arthritis and arthritis in KBN mice. As spontaneous arthritides, human TNF-α transgenic mice are a reliable model. It is mandatory to use animal models in the respect of ethical procedure, particularly regarding the number of animals and the control of pain. Moreover, design of experiments should be of the highest level, animal models of arthritis being dedicated to exploration of well-based novelties, and never used for confirmation or replication of already proven concepts. The best interpretations of data in animal models of arthritis suppose integrated research, including translational studies from animals to humans.

Bernard C (1865) Introduction à l‘étude de la médecine expérimentale, vol 1. JB Baillère et Fils, Paris

Webb DR (2014) Animal models of human disease: inflammation. Biochem Pharmacol 87:121–130. doi:10.1016/j.bcp.2013.06.014 PubMedCrossRef

Takao K, Miyakawa T (2015) Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 112:1167–1172. doi:10.1073/pnas.1401965111 PubMedCrossRef

Stoerk H (1954) Chronic polyarthritis in rats injected with spleen in adjuvants. 30:616–621

Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med Soc Exp Biol Med N Y N 91:95–101CrossRef

Seok J, Warren HS, Cuenca AG et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110:3507–3512. doi:10.1073/pnas.1222878110 PubMedPubMedCentralCrossRef

Pound P, Bracken MB (2014) Is animal research sufficiently evidence based to be a cornerstone of biomedical research? BMJ 348:g3387PubMedCrossRef

Segura E, Touzot M, Bohineust A et al (2013) Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38:336–348PubMedCrossRef

Narendra SC, Chalise JP, Hook N, Magnusson M (2014) Dendritic cells activated by double-stranded RNA induce arthritis via autocrine type I IFN signaling. J Leukoc Biol 95:661–666PubMedCrossRef

10.

Hoffmann MH, Skriner K, Herman S et al (2011) Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis. J Autoimmun 36:288–300PubMedCrossRef

11.

Tak PP, Smeets TJ, Daha MR et al (1997) Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 40:217–225PubMedCrossRef

12.

Joosten LA, Helsen MM, van de Loo FA, van den Berg WB (1996) Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum 39:797–809PubMedCrossRef

13.

Zhu W, Li X, Fang S et al (2015) Anti-citrullinated protein antibodies induce macrophage subset disequilibrium in RA patients. Inflammation 38:2067–2075PubMedCrossRef

14.

Misharin AV, Cuda CM, Saber R et al (2014) Nonclassical Ly6C(−) monocytes drive the development of inflammatory arthritis in mice. Cell Rep 9:591–604PubMedPubMedCentralCrossRef

15.

Li J, Hsu HC, Ding Y et al (2014) Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis. Arthritis Rheumatol 66:2368–2379PubMedPubMedCentralCrossRef

16.

Shimizu K, Nakajima A, Sudo K et al (2015) IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages. JImmunol 194:3156–3168CrossRef

17.

Cook AD, Braine EL, Campbell IK et al (2001) Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res 3:293–298PubMedPubMedCentralCrossRef

18.

Campbell IK, Rich MJ, Bischof RJ, Hamilton JA (2000) The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol 68:144–150PubMed

19.

Pillay J, den Braber I, Vrisekoop N et al (2010) In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116:625–627PubMedCrossRef

20.

Puga I, Cols M, Barra C et al (2012) B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 13:170–250CrossRef

21.

Zhang X, Majlessi L, Deriaud E et al (2009) Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 31:761–771PubMedCrossRef

22.

Lindau D, Mussard J, Rabsteyn A et al (2014) TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen. Ann Rheum Dis 73:2199–2207PubMedCrossRef

23.

Decker P (2011) Neutrophils and interferon-alpha-producing cells: who produces interferon in lupus? Arthritis ResTher 13:118CrossRef

24.

Iking-Konert C, Ostendorf B, Sander O et al (2005) Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann Rheum Dis 64:1436–1442PubMedPubMedCentralCrossRef

25.

Poubelle PE, Chakravarti A, Fernandes MJ et al (2007) Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Res Ther 9:R25PubMedPubMedCentralCrossRef

26.

Tanaka D, Kagari T, Doi H, Shimozato T (2006) Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 119:195–202PubMedPubMedCentralCrossRef

27.

Wang JX, Bair AM, King SL et al (2012) Ly6G ligation blocks recruitment of neutrophils via a beta2-integrin-dependent mechanism. Blood 120:1489–1498PubMedPubMedCentralCrossRef

28.

Lawlor KE, Campbell IK, Metcalf D et al (2004) Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc Natl Acad Sci U S A 101:11398–11403PubMedPubMedCentralCrossRef

29.

Eyles JL, Hickey MJ, Norman MU et al (2008) A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 112:5193–5201PubMedCrossRef

30.

Campbell IK, Leong D, Edwards KM et al (2016) Therapeutic targeting of the G-CSF receptor reduces neutrophil trafficking and joint inflammation in antibody-mediated inflammatory arthritis. J Immunol 197:4392–4402PubMedCrossRef

31.

Chou RC, Kim ND, Sadik CD et al (2010) Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33:266–278PubMedPubMedCentralCrossRef

32.

Niki Y, Yamada H, Seki S et al (2001) Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice. J Clin Invest 107:1127–1135PubMedPubMedCentralCrossRef

33.

Martin P, Palmer G, Rodriguez E et al (2017) Deficiency in IL-1 receptor type 2 aggravates K/BxN serum transfer-induced arthritis in mice but has no impact on systemic inflammatory responses. J Immunol Baltim Md 1950. doi:10.4049/jimmunol.1600855

34.

Brinkmann V, Reichard U, Goosmann C et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535PubMedCrossRef

35.

Li P, Li M, Lindberg MR et al (2010) PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 207:1853–1862PubMedPubMedCentralCrossRef

36.

Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A et al (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5:178ra40PubMedPubMedCentralCrossRef

37.

Pratesi F, Dioni I, Tommasi C, et al (2014) Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis 73:1414–1422

38.

Spengler J, Lugonja B, Ytterberg AJ et al (2015) Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol 67:3135–3145PubMedPubMedCentralCrossRef

39.

Papadaki G, Kambas K, Choulaki C et al (2016) Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol 46:2542–2554PubMedPubMedCentralCrossRef

40.

Kawalkowska J, Quirke AM, Ghari F et al (2016) Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses. Sci Rep 6:26430PubMedPubMedCentralCrossRef

41.

Willis VC, Gizinski AM, Banda NK et al (2011) N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 186:4396–4404PubMedPubMedCentralCrossRef

42.

Rohrbach AS, Hemmers S, Arandjelovic S et al (2012) PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis. Arthritis Res Ther 14:R104PubMedPubMedCentralCrossRef

43.

Monach PA, Hueber W, Kessler B et al (2009) A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proc Natl Acad Sci U A 106:15867–15872CrossRef

44.

Yu D, Rumore PM, Liu Q, Steinman CR (1997) Soluble oligonucleosomal complexes in synovial fluid from inflamed joints. Arthritis Rheum 40:648–654PubMedCrossRef

45.

Ronnefarth VM, Erbacher AI, Lamkemeyer T et al (2006) TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. J Immunol 177:7740–7749PubMedCrossRef

46.

Lindau D, Ronnefarth V, Erbacher A et al (2011) Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Eur J Immunol 41:669–681PubMedCrossRef

47.

Decker P, Singh-Jasuja H, Haager S et al (2005) Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J Immunol 174:3326–3334PubMedCrossRef

48.

Gravallese EM, Harada Y, Wang JT et al (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943–951PubMedPubMedCentral

49.

Zaiss MM, Axmann R, Zwerina J et al (2007) Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum 56:4104–4112PubMedCrossRef

50.

Kim KW, Cho ML, Oh HJ et al (2009) TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Immunol Lett 124:9–17PubMedCrossRef

51.

Yeo L, Toellner KM, Salmon M et al (2011) Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis 70:2022–2028PubMedPubMedCentralCrossRef

52.

Krishnamurthy A, Joshua V, Haj HA et al (2016) Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis 75:721–729PubMedCrossRef

53.

Danks L, Komatsu N, Guerrini MM et al (2016) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75:1187–1195PubMedCrossRef

54.

Feng X, Shi Y, Xu L et al (2016) Modulation of IL-6 induced RANKL expression in arthritic synovium by a transcription factor SOX5. SciRep 6:32001

55.

LaBranche TP, Jesson MI, Radi ZA et al (2012) JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. Arthritis Rheum 64:3531–3542PubMedCrossRef

56.

Charles JF, Hsu LY, Niemi EC et al (2012) Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest 122:4592–4605PubMedPubMedCentralCrossRef

57.

Zhang AL, Colmenero P, Purath U et al (2007) Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 110:2484–2493PubMedPubMedCentralCrossRef

58.

Soderstrom K, Stein E, Colmenero P et al (2010) Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci U S A 107:13028–13033PubMedCrossRef

59.

Andersson AK, Sumariwalla PF, McCann FE et al (2011) Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis. Arthritis Rheum 63:2617–2629PubMedCrossRef

60.

Groh V, Bruhl A, El Gabalawy H et al (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 100:9452–9457PubMedPubMedCentralCrossRef

61.

Bradfield PF, Amft N, Vernon-Wilson E et al (2003) Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum 48:2472–2482PubMedCrossRef

62.

Lefevre S, Knedla A, Tennie C et al (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15:1414–1420PubMedPubMedCentralCrossRef

63.

Hu F, Li Y, Zheng L et al (2014) Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis. PLoS One 9:e100266PubMedPubMedCentralCrossRef

64.

Zhu W, Meng L, Jiang C et al (2011) Arthritis is associated with T-cell-induced upregulation of toll-like receptor 3 on synovial fibroblasts. Arthritis Res Ther 13:R103PubMedPubMedCentralCrossRef

65.

Huang Q, Ma Y, Adebayo A, Pope RM (2007) Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum 56:2192–2201PubMedCrossRef

66.

Abdollahi-Roodsaz S, Joosten LA, Roelofs MF et al (2007) Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 56:2957–2967PubMedCrossRef

67.

Pierer M, Wagner U, Rossol M, Ibrahim S (2011) Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice. PLoS One 6:e23539PubMedPubMedCentralCrossRef

68.

Kim HS, Chung DH (2012) TLR4-mediated IL-12 production enhances IFN-gamma and IL-1beta production, which inhibits TGF-beta production and promotes antibody-induced joint inflammation. Arthritis Res Ther 14:R210PubMedPubMedCentralCrossRef

69.

Taniguchi N, Kawahara K, Yone K et al (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971–981PubMedCrossRef

70.

Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al (2008) Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118:205–216PubMedCrossRef

71.

Hayashi T, Gray CS, Chan M et al (2009) Prevention of autoimmune disease by induction of tolerance to toll-like receptor 7. Proc Natl Acad Sci U S A 106:2764–2769PubMedPubMedCentralCrossRef

72.

Alzabin S, Kong P, Medghalchi M et al (2012) Investigation of the role of endosomal toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance. Arthritis Res Ther 14:R142PubMedPubMedCentralCrossRef

73.

Kim SJ, Chen Z, Essani AB et al (2016) Identification of a novel toll-like receptor 7 endogenous ligand in rheumatoid arthritis synovial fluid that can provoke arthritic joint inflammation. Arthritis Rheumatol 68:1099–1110PubMedPubMedCentral

74.

Lacerte P, Brunet A, Egarnes B et al (2016) Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists. Arthritis Res Ther 18:10PubMedPubMedCentralCrossRef

75.

Hemmi H, Takeuchi O, Kawai T et al (2000) A toll-like receptor recognizes bacterial DNA. Nature 408:740–745PubMedCrossRef

76.

Deng GM, Nilsson IM, Verdrengh M et al (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5:702–705PubMedCrossRef

77.

Lindau D, Mussard J, Wagner BJ et al (2013) Primary blood neutrophils express a functional cell surface toll-like receptor 9. Eur J Immunol 43:2101–2113PubMedCrossRef

78.

Asagiri M, Hirai T, Kunigami T et al (2008) Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319:624–627PubMedCrossRef

79.

Carrion M, Juarranz Y, Perez-Garcia S et al (2011) RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Arthritis Rheum 63:1626–1636PubMedCrossRef

80.

Magnusson M, Zare F, Tarkowski A (2006) Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum 54:148–157PubMedCrossRef

81.

Yarilina A, DiCarlo E, Ivashkiv LB (2007) Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol 178:2204–2211PubMedCrossRef

82.

Kawane K, Ohtani M, Miwa K et al (2006) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998–1002PubMedCrossRef

83.

Neidhart M, Karouzakis E, Schumann GG et al (2010) Trex-1 deficiency in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 62:2673–2679PubMedCrossRef

84.

Clavel C, Nogueira L, Laurent L et al (2008) Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 58:678–688PubMedCrossRef

85.

Sokolove J, Zhao X, Chandra PE, Robinson WH (2011) Immune complexes containing citrullinated fibrinogen costimulate macrophages via toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum 63:53–62PubMedPubMedCentralCrossRef

86.

Ben Mkaddem S, Hayem G, Jonsson F et al (2014) Shifting FcgammaRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J Clin Invest 124:3945–3959PubMedPubMedCentralCrossRef

87.

Boross P, van Lent PL, Martin-Ramirez J et al (2008) Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII. J Immunol 180:5083–5091PubMedCrossRef

88.

Seeling M, Hillenhoff U, David JP et al (2013) Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A 110:10729–10734PubMedPubMedCentralCrossRef

89.

Espeli M, Clatworthy MR, Bokers S et al (2012) Analysis of a wild mouse promoter variant reveals a novel role for FcgammaRIIb in the control of the germinal center and autoimmunity. J Exp Med 209:2307–2319PubMedPubMedCentralCrossRef

90.

Trouw LA, Daha N, Kurreeman FA et al (2013) Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis. Clin Exp Immunol 173:76–83PubMedPubMedCentralCrossRef

91.

Trouw LA, Haisma EM, Levarht EW et al (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 60:1923–1931PubMedCrossRef

92.

Ji H, Ohmura K, Mahmood U et al (2002) Arthritis critically dependent on innate immune system players. Immunity 16:157–168PubMedCrossRef

93.

Banda NK, Takahashi K, Wood AK et al (2007) Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. JImmunol 179:4101–4109CrossRef

94.

Strainic MG, Liu J, Huang D et al (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28:425–435PubMedPubMedCentralCrossRef

95.

Jose PJ, Moss IK, Maini RN, Williams TJ (1990) Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis 49:747–752PubMedPubMedCentralCrossRef

96.

Sadik CD, Kim ND, Iwakura Y, Luster AD (2012) Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcgammaR signaling. Proc Natl Acad Sci U S A 109:E3177–E3185PubMedPubMedCentralCrossRef

97.

Tsuboi N, Ernandez T, Li X et al (2011) Regulation of human neutrophil Fcgamma receptor IIa by C5a receptor promotes inflammatory arthritis in mice. Arthritis Rheum 63:467–478PubMedPubMedCentralCrossRef

98.

Kessel C, Nandakumar KS, Peters FB et al (2014) A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis. Arthritis Rheumatol 66:610–621PubMedPubMedCentralCrossRef

99.

Andersson C, Wenander CS, Usher PA et al (2014) Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model. Clin Exp Immunol 177:219–233PubMedPubMedCentralCrossRef

100.

Dimitrova P, Ivanovska N, Belenska L et al (2012) Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis. Arthritis Res Ther 14:R173PubMedPubMedCentralCrossRef

101.

Svensson L, Jirholt J, Holmdahl R, Jansson L (1998) B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111:521–526PubMedPubMedCentralCrossRef

102.

Schellekens GA, de Jong BA, van den Hoogen FH et al (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. JClinInvest 101:273–281

103.

Girbal-Neuhauser E, Durieux JJ, Arnaud M et al (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deimination of arginine residues. J Immunol 162:585–594PubMed

104.

Clavel C, Ceccato L, Anquetil F, et al (2016) Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA. Ann Rheum Dis 75:2184–2191

105.

Harre U, Georgess D, Bang H, et al (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791–1802

106.

Kidd BA, Ho PP, Sharpe O et al (2008) Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther 10:R119PubMedPubMedCentralCrossRef

107.

Kuhn KA, Kulik L, Tomooka B et al (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116:961–973PubMedPubMedCentralCrossRef

108.

Uysal H, Bockermann R, Nandakumar KS et al (2009) Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 206:449–462PubMedPubMedCentralCrossRef

109.

Vossenaar ER, Nijenhuis S, Helsen MM et al (2003) Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 48:2489–2500PubMedCrossRef

110.

Cantaert T, Teitsma C, Tak PP, Baeten D (2013) Presence and role of anti-citrullinated protein antibodies in experimental arthritis models. Arthritis Rheum 65:939–948PubMedCrossRef

111.

Duplan V, Foulquier C, Clavel C et al (2006) In the rat, citrullinated autologous fibrinogen is immunogenic but the induced autoimmune response is not arthritogenic. Clin Exp Immunol 145:502–512PubMedPubMedCentralCrossRef

112.

Benham H, Nel HJ, Law SC et al (2015) Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci Transl Med 7:290ra87PubMedCrossRef

113.

Darrah E, Giles JT, Ols ML et al (2013) Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci Transl Med 5:186ra65PubMedPubMedCentralCrossRef

114.

Khalifeh MS, Al Rukibat R, Hananeh W et al (2010) Investigation of the role of tumour necrosis factor-{alpha}, interleukin-1{beta}, interleukin-10, nitric oxide and rheumatoid factor-immunoglobulin M in a rat model of arthritis. Lab Anim 44:143–149PubMedCrossRef

115.

Laurent L, Anquetil F, Clavel C et al (2015) IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies. Ann Rheum Dis 74:1425–1431PubMedCrossRef

116.

Anquetil F, Clavel C, Offer G et al (2015) IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies. J Immunol 194:3664–3674PubMedCrossRef

117.

Shi J, Knevel R, Suwannalai P et al (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 108:17372–17377PubMedPubMedCentralCrossRef

118.

Brink M, Verheul MK, Ronnelid J et al (2015) Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis Res Ther 17:25PubMedPubMedCentralCrossRef

119.

Stoop JN, Fischer A, Hayer S et al (2015) Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system. Ann Rheum Dis 74:949–950PubMedCrossRef

120.

Stoop JN, Liu BS, Shi J et al (2014) Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis. PLoS One 9:e102163PubMedPubMedCentralCrossRef

121.

Carter NA, Vasconcellos R, Rosser EC et al (2011) Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 186:5569–5579PubMedCrossRef

122.

Daien CI, Gailhac S, Mura T et al (2014) Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheumatol 66:2037–2046PubMedCrossRef

123.

Chu CQ, Londei M (1996) Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs. J Immunol Baltim Md 1950 157:2685–2689

124.

Goldschmidt TJ, Andersson M, Malmström V, Holmdahl R (1992) Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis. Immunobiology 184:359–371. doi:10.1016/S0171-2985(11)80593-0 PubMedCrossRef

125.

Banerjee S, Webber C, Poole AR (1992) The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol 144:347–357PubMedCrossRef

126.

Duarte J, Agua-Doce A, Oliveira VG et al (2010) Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. PLoS One 5:e10558PubMedPubMedCentralCrossRef

127.

Schubert D, Maier B, Morawietz L et al (2004) Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol Baltim Md 1950 172:4503–4509

128.

Van den Broek MF, Van de Langerijt LG, Van Bruggen MC et al (1992) Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. Eur J Immunol 22:57–61. doi:10.1002/eji.1830220110 PubMedCrossRef

129.

Sakaguchi N, Takahashi T, Hata H et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454–460PubMedCrossRef

130.

Kis-Toth K, Radacs M, Olasz K et al (2012) Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice. Int Immunol 24:507–517. doi:10.1093/intimm/dxs057 PubMedPubMedCentralCrossRef

131.

Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74:5–17. doi:10.1016/j.cyto.2014.09.011 PubMedCrossRef

132.

Geginat J, Paroni M, Maglie S et al (2014) Plasticity of human CD4 T cell subsets. Front Immunol 5:630. doi:10.3389/fimmu.2014.00630 PubMedPubMedCentralCrossRef

133.

Boissier MC, Chiocchia G, Bessis N et al (1995) Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol 25:1184–1190PubMedCrossRef

134.

Alzabin S, Williams RO (2011) Effector T cells in rheumatoid arthritis: lessons from animal models. FEBS Lett 585:3649–3659. doi:10.1016/j.febslet.2011.04.034 PubMedCrossRef

135.

van Hamburg JP, Asmawidjaja PS, Davelaar N et al (2011) Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum 63:73–83. doi:10.1002/art.30093 PubMedCrossRef

136.

Evans HG, Gullick NJ, Kelly S et al (2009) In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A 106:6232–6237. doi:10.1073/pnas.0808144106 PubMedPubMedCentralCrossRef

137.

Lubberts E, Joosten LA, Oppers B et al (1950) (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol Baltim Md 167:1004–1013

138.

Lubberts E, Koenders MI, Oppers-Walgreen B et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659. doi:10.1002/art.20001 PubMedCrossRef

139.

Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177PubMedCrossRef

140.

Nakae S, Saijo S, Horai R et al (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 100:5986–5990. doi:10.1073/pnas.1035999100 PubMedPubMedCentralCrossRef

141.

Koenders MI, Kolls JK, Oppers-Walgreen B et al (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 52:3239–3247. doi:10.1002/art.21342 PubMedCrossRef

142.

Jacobs JP, Wu H-J, Benoist C, Mathis D (2009) IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci U S A 106:21789–21794. doi:10.1073/pnas.0912152106 PubMedPubMedCentralCrossRef

143.

Auger JL, Cowan HM, Engelson BJ et al (2016) Brief report: arthritis in KRN T cell receptor-transgenic mice does not require interleukin-17 or Th17 cells. Arthritis Rheumatol Hoboken NJ 68:1849–1855. doi:10.1002/art.39646 CrossRef

144.

Doodes PD, Cao Y, Hamel KM et al (2008) Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol Baltim Md 1950 181:329–337

145.

Pandya JM, Lundell A-C, Hallström M et al (2016) Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects. J Leukoc Biol 100:823–833. doi:10.1189/jlb.5A0116-025R PubMedCrossRef

146.

Lavocat F, Maggi L, Annunziato F, Miossec P (2016) T-cell clones from Th1, Th17 or Th1/17 lineages and their signature cytokines have different capacity to activate endothelial cells or synoviocytes. Cytokine 88:241–250. doi:10.1016/j.cyto.2016.09.019 PubMedCrossRef

147.

Murphy CA, Langrish CL, Chen Y et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957PubMedPubMedCentralCrossRef

148.

Yago T, Nanke Y, Kawamoto M et al (2007) IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther 9:R96. doi:10.1186/ar2297 PubMedPubMedCentralCrossRef

149.

Ratsimandresy R, Duvallet E, Assier E et al (2011) Active immunization against IL-23p19 improves experimental arthritis. Vaccine 29:9329–9365PubMedCrossRef

150.

Cornelissen F, Asmawidjaja PS, Mus AMC et al (2013) IL-23 dependent and independent stages of experimental arthritis: no clinical effect of therapeutic IL-23p19 inhibition in collagen-induced arthritis. PLoS One 8:e57553. doi:10.1371/journal.pone.0057553 PubMedPubMedCentralCrossRef

151.

Cornelissen F, Mus AM, Asmawidjaja PS et al (2009) Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells. Arthritis Res Ther 11:R194. doi:10.1186/ar2893 PubMedPubMedCentralCrossRef

152.

Lemos HP, Grespan R, Vieira SM et al (2009) Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A 106:5954–5959. doi:10.1073/pnas.0812782106 PubMedPubMedCentralCrossRef

153.

Fragoulis GE, Siebert S, McInnes IB (2016) Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases. Annu Rev Med 67:337–353. doi:10.1146/annurev-med-051914-021944 PubMedCrossRef

154.

Bessis N, Cottard V, Saidenberg-Kermanach’ N et al (2002) Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis. J Gene Med 4:300–307PubMedCrossRef

155.

Cottard V, Mulleman D, Bouille P et al (2000) Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther 7:1930–1939PubMedCrossRef

156.

Horsfall AC, Butler DM, Marinova L et al (1997) Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 159:5687–5696PubMed

157.

Joosten LA, Lubberts E, Helsen MM et al (1999) Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 1:81–91. doi:10.1186/ar14 PubMedPubMedCentralCrossRef

158.

Cao Y, Brombacher F, Tunyogi-Csapo M et al (2007) Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum 56:861–870. doi:10.1002/art.22422 PubMedCrossRef

159.

Yoshino S (1998) Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice. Br J Pharmacol 123:237–242. doi:10.1038/sj.bjp.0701607 PubMedPubMedCentralCrossRef

160.

Ohmura K, Nguyen LT, Locksley RM et al (2005) Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis Rheum 52:1866–1875. doi:10.1002/art.21104 PubMedCrossRef

161.

van Roon JAG, Bijlsma JWJ (2002) Th2 mediated regulation in RA and the spondyloarthropathies. Ann Rheum Dis 61:951–954PubMedPubMedCentralCrossRef

162.

Rasmussen TK (2016) Follicular T helper cells and IL-21 in rheumatic diseases. Dan Med J 63

163.

Sakuraba K, Oyamada A, Fujimura K et al (2016) Interleukin-21 signaling in B cells, but not in T cells, is indispensable for the development of collagen-induced arthritis in mice. Arthritis Res Ther 18:188. doi:10.1186/s13075-016-1086-y PubMedPubMedCentralCrossRef

164.

Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164PubMed

165.

Buckner JH (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10:849–859. doi:10.1038/nri2889 PubMedPubMedCentralCrossRef

166.

Mottonen M, Heikkinen J, Mustonen L et al (2005) CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140:360–367PubMedPubMedCentralCrossRef

167.

Sarkar S, Fox DA (2007) Regulatory T cell defects in rheumatoid arthritis. Arthritis Rheum 56:710–713. doi:10.1002/art.22415 PubMedCrossRef

168.

Ehrenstein MR, Evans JG, Singh A et al (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277–285PubMedPubMedCentralCrossRef

169.

Rapetti L, Chavele K-M, Evans CM, Ehrenstein MR (2015) B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 74:294–302. doi:10.1136/annrheumdis-2013-204049 PubMedCrossRef

170.

Morgan ME, Flierman R, van Duivenvoorde LM et al (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52:2212–2221PubMedCrossRef

171.

Frey O, Reichel A, Bonhagen K et al (2010) Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis. Ann Rheum Dis 69:1511–1518. doi:10.1136/ard.2009.123422 PubMedCrossRef

172.

Frey O, Petrow PK, Gajda M et al (2005) The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7:R291–R301. doi:10.1186/ar1484 PubMedPubMedCentralCrossRef

173.

Biton J, Semerano L, Delavallee L et al (2011) Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J Immunol 186:3899–3910PubMedCrossRef

174.

Nadkarni S, Mauri C, Ehrenstein MR (2007) Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 204:33–39PubMedPubMedCentralCrossRef

175.

Nguyen DX, Ehrenstein MR (2016) Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis. J Exp Med 213:1241–1253. doi:10.1084/jem.20151255 PubMedPubMedCentralCrossRef

176.

Thiolat A, Semerano L, Pers YM et al (2014) Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol Hoboken NJ 66:273–283. doi:10.1002/art.38246 CrossRef

177.

Barbi J, Pardoll D, Pan F (2014) Treg functional stability and its responsiveness to the microenvironment. Immunol Rev 259:115–139. doi:10.1111/imr.12172 PubMedPubMedCentralCrossRef

178.

Zheng SG, Wang J, Horwitz DA (2008) Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol Baltim Md 1950 180:7112–7116

179.

Lal G, Zhang N, van der Touw W et al (2009) Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol Baltim Md 1950 182:259–273

180.

Semerano L, Clavel G, Assier E et al (2011) Blood vessels, a potential therapeutic target in rheumatoid arthritis? Jt Bone Spine Rev Rhum 78:118–123. doi:10.1016/j.jbspin.2010.06.004 CrossRef

181.

Clavel G, Valvason C, Yamaoka K et al (2006) Relationship between angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw 17:202–210PubMed

182.

Jain A, Nanchahal J, Troeberg L et al (2001) Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. Arthritis Rheum 44:1754–1760. doi:10.1002/1529-0131(200108)44:8<1754::AID-ART310>3.0.CO;2-8 PubMedCrossRef

183.

Ballara S, Taylor PC, Reusch P et al (2001) Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 44:2055–2064. doi:10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2 PubMedCrossRef

184.

Lu J, Kasama T, Kobayashi K et al (2000) Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol Baltim Md 1950 164:5922–5927

185.

Semerano L, Duvallet E, Belmellat N et al (2016) Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis. Angiogenesis 19:39–52. doi:10.1007/s10456-015-9487-0 PubMedCrossRef

186.

Hu F, Mu R, Zhu J et al (2014) Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis 73:928–936. doi:10.1136/annrheumdis-2012-202444 PubMedCrossRef

187.

Cramer T, Yamanishi Y, Clausen BE et al (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645–657PubMedPubMedCentralCrossRef

188.

Lee DM, Phillips R, Hagan EM et al (2009) Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 68:201–208. doi:10.1136/ard.2007.084509 PubMedCrossRef

189.

Sugiyama D, Nishimura K, Tamaki K et al (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69:70–81. doi:10.1136/ard.2008.096487 PubMedCrossRef

190.

Karlson EW, Chang S-C, Cui J et al (2010) Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 69:54–60. doi:10.1136/ard.2008.102962 PubMedCrossRef

191.

Vessey MP, Villard-Mackintosh L, Yeates D (1987) Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 35:457–464PubMedCrossRef

192.

Vassallo R, Luckey D, Behrens M et al (2014) Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes. Clin Immunol Orlando Fla 152:25–35. doi:10.1016/j.clim.2014.02.002 CrossRef

193.

Okamoto S, Adachi M, Chujo S et al (2011) Etiological role of cigarette smoking in rheumatoid arthritis: nasal exposure to cigarette smoke condensate extracts augments the development of collagen-induced arthritis in mice. Biochem Biophys Res Commun 404:1088–1092. doi:10.1016/j.bbrc.2010.12.118 PubMedCrossRef

194.

Allais L, Kumar S, Debusschere K et al (2015) The effect of cigarette smoke exposure on the development of inflammation in lungs, gut and joints of TNFΔARE mice. PLoS One 10:e0141570. doi:10.1371/journal.pone.0141570 PubMedPubMedCentralCrossRef

195.

Vaahtovuo J, Munukka E, Korkeamäki M et al (2008) Fecal microbiota in early rheumatoid arthritis. J Rheumatol 35:1500–1505PubMed

196.

Liu X, Zou Q, Zeng B et al (2013) Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol 67:170–176. doi:10.1007/s00284-013-0338-1 PubMedCrossRef

197.

Chen J, Wright K, Davis JM et al (2016) An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med 8:43. doi:10.1186/s13073-016-0299-7 PubMedPubMedCentralCrossRef

198.

Zhang X, Zhang D, Jia H et al (2015) The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21:895–905. doi:10.1038/nm.3914 PubMedCrossRef

199.

Maeda Y, Kurakawa T, Umemoto E et al (2016) Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol Hoboken NJ 68:2646–2661. doi:10.1002/art.39783 CrossRef

200.

Teng F, Klinger CN, Felix KM et al (2016) Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer’s patch T follicular helper cells. Immunity 44:875–888. doi:10.1016/j.immuni.2016.03.013 PubMedPubMedCentralCrossRef

201.

Wu H-J, Ivanov II, Darce J et al (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:815–827. doi:10.1016/j.immuni.2010.06.001 PubMedPubMedCentralCrossRef

202.

Williams RO, Feldmann M, Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U A 89:9784–9788CrossRef

203.

Keffer J, Probert L, Cazlaris H et al (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031PubMedPubMedCentral

204.

Feldmann M, Maini RN (2010) Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us? J Immunol Baltim Md 1950 185:791–794. doi:10.4049/jimmunol.1090051

205.

Biton J, Boissier MC, Bessis N (2011) TNFalpha: activator or inhibitor of regulatory T cells? Joint Bone Spine 79:119–123PubMedCrossRef

206.

Le Buanec H, Delavallee L, Bessis N et al (2006) TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation. Proc Natl Acad Sci U A 103:19442–19447CrossRef

207.

Peres RS, Liew FY, Talbot J et al (2015) Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc Natl Acad Sci U S A 112:2509–2514. doi:10.1073/pnas.1424792112 PubMedPubMedCentralCrossRef

208.

Hammaker D, Firestein GS (2010) “Go upstream, young man”: lessons learned from the p38 saga. Ann Rheum Dis 69(Suppl 1):i77–i82. doi:10.1136/ard.2009.119479 PubMedPubMedCentralCrossRef

209.

Semerano L, Decker P, Clavel G, Boissier M-C (2016) Developments with investigational Janus kinase inhibitors for rheumatoid arthritis. Expert Opin Investig Drugs 25:1355–1359. doi:10.1080/13543784.2016.1249565 PubMedCrossRef

210.

Brühl H, Cihak J, Talke Y et al (2015) B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis. Eur J Immunol 45:705–715. doi:10.1002/eji.201444971 PubMedCrossRef

211.

Courtenay JS, Dallman MJ, Dayan AD et al (1980) Immunisation against heterologous type II collagen induces arthrtis in mice. Nature 283:666–668PubMedCrossRef

212.

Campbell IK, Hamilton JA, Wicks IP (2000) Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568–1575PubMedCrossRef

213.

Wieschowski S, Silva DS, Strech D (2016) Animal study registries: results from a stakeholder analysis on potential strengths, weaknesses, facilitators, and barriers. PLoS Biol 14:e2000391. doi:10.1371/journal.pbio.2000391 PubMedPubMedCentralCrossRef

214.

Hawkins P, Armstrong R, Boden T et al (2015) Applying refinement to the use of mice and rats in rheumatoid arthritis research. Inflammopharmacology 23:131–150. doi:10.1007/s10787-015-0241-4 PubMedPubMedCentralCrossRef

Titel: Arthritis models: usefulness and interpretation
verfasst von: Natacha Bessis
Patrice Decker
Eric Assier
Luca Semerano
Marie-Christophe Boissier
Publikationsdatum: 27.03.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Seminars in Immunopathology / Ausgabe 4/2017
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-017-0622-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Arthritis models: usefulness and interpretation

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Synovial cellular and molecular markers in rheumatoid arthritis

Epigenetics in the pathogenesis of RA

Cellular and molecular pathways of structural damage in rheumatoid arthritis

The role of autoantibodies in the pathophysiology of rheumatoid arthritis

Genetics of rheumatoid arthritis susceptibility, severity, and treatment response

Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin